Video Experimental Relacionado
Updated: Jul 17, 2026
10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Dinámica estructural de la unión cooperativa de moléculas orgánicas en el citocromo humano P450 3A4
Dan Fishelovitch1, Carina Hazan, Sason Shaik
1Department of Human Genetics, Sackler Institute of Molecular Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Journal of the American Chemical Society
|February 8, 2007
Resumen
La cinética de las enzimas del citocromo P450 3A4 (CYP3A4) muestra una unión cooperativa al sustrato. La dinámica molecular revela que las moléculas efectoras estabilizan los residuos clave, optimizando el metabolismo de los fármacos mediante la colocación de sustratos para una eficiente abstracción de hidrógeno.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Enzimología Enzimología.
- Farmacología Farmacología.
Sus antecedentes:
- El citocromo P450 3A4 (CYP3A4) metaboliza el 50% de las drogas orales.
- El CYP3A4 exhibe cinética sigmoidal, lo que indica una unión cooperativa al sustrato.
- El mecanismo de esta vinculación cooperativa sigue sin estar claro.
Objetivo del estudio:
- Para dilucidar el mecanismo de unión cooperativa al sustrato en el CYP3A4.4.
- Comprender cómo los sustratos efectores influyen en el sitio activo y el metabolismo de los fármacos.
- Para investigar el papel de los residuos específicos en la unión cooperativa del CYP3A4.
Principales métodos:
- Simulaciones de dinámica molecular del CYP3A4 con diazepam.
- Análisis de conformadores enzimáticos con unión libre de sustrato, de un solo sustrato y de doble sustrato.
- Examen de las interacciones de los residuos y su impacto en la orientación del sustrato.
Principales resultados:
- Un sustrato efector interactúa tanto con el sustrato activo como con la enzima, reorientando las cadenas laterales.
- El residuo F304 es crucial para la unión cooperativa, estabilizando su entorno en la unión del efector.
- La estabilización por el efector conduce a una orientación favorable del sustrato activo para la abstracción de hidrógeno.
Conclusiones:
- La unión cooperativa en CYP3A4 está mediada por la estabilización inducida por el efector de residuos clave como F304.4.
- Esta estabilización optimiza el sitio activo para un metabolismo eficiente de la droga.
- La conformación enzimática y las interacciones de residuos (por ejemplo, R212-F304) pueden modular la influencia del efector.
Videos de Conceptos Relacionados
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
02:13Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
02:13Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...